Document is current
Any future updates will be listed below
-
Authors
Cheng, Chung-wah
Mok, Hoi-fung
Yau, Cora W. S.
Chan, Jasmine T. M.
Kang, Yu-chen
Lam, Pui-yan
Zhong, Linda L. D.
Zhao, Chen
Ng, Bacon F. L.
Kwok, Annie O. L.
Tse, Doris M. W.
Bian, Zhao-xiang http://orcid.org/0000-0001-6206-1958
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02795390 at ClinicalTrials.govDocuments that mention this clinical trial
A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients
https://doi.org/10.1186/s13020-022-00580-0
-
Funding
Funding for this research was provided by:
Hospital Authority (HA 105/48 PT24)
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 3 February 2022
First Online: 2 March 2022
Declarations
:
: The study was conducted in accordance with the World Medical Association Declaration of Helsinki and the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Institutional Review Board approval was obtained from the Kowloon West Cluster [KW/FR-16–077(98–20(TCM)] and Kowloon Central/Kowloon East Cluster [KC/KE-17–0116/ER-3] of Hospital Authority Research Ethics Committees, and the Hong Kong Baptist University [HASC/15–16/0316]. All participants provided their written informed consent before participating this study.
: Not applicable.
: The authors declare that there is no conflict of interest.
